Acceptance Of A Partially-Hydrolyzed Infant Formula

NCT ID: NCT03223792

Last Updated: 2019-01-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-08-21

Study Completion Date

2018-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This clinical trial will evaluate stool consistency in infants receiving one of two study formulas through a 14-day feeding period.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stool

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

TRIPLE

Participants Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

Group Type ACTIVE_COMPARATOR

Control

Intervention Type OTHER

Routine cow's milk-based infant formula

Investigational

Group Type EXPERIMENTAL

Investigational

Intervention Type OTHER

Partially-hydrolyzed cow's milk protein infant formula

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Control

Routine cow's milk-based infant formula

Intervention Type OTHER

Investigational

Partially-hydrolyzed cow's milk protein infant formula

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Singleton 28-300 days of age at randomization
* Gestational age less than or equal to 35 weeks
* Receiving minimum 18oz infant formula in the 24hrs prior to randomization
* History of hard stools or stooling difficulty
* Signed informed consent and protected health information

Exclusion Criteria

* Current diagnosis of cow's milk protein allergy or intolerance
* Use of extensively hydrolyzed or amino acid formula at randomization
* Any abdominal or gastrointestinal surgery prior to randomization
* History of underlying metabolic or chronic disease or congenital malformation
* Organic causes of constipation
Minimum Eligible Age

28 Days

Maximum Eligible Age

300 Days

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mead Johnson Nutrition

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Steven Wu

Role: STUDY_DIRECTOR

Mead Johnson Nutrition

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Birmingham Pediatric Associates

Birmingham, Alabama, United States

Site Status

Southeastern Pediatric Associates

Dothan, Alabama, United States

Site Status

Northwest Arkansas Pediatric Clinic

Fayetteville, Arkansas, United States

Site Status

The Children's Clinic of Jonesboro, P.A.

Jonesboro, Arkansas, United States

Site Status

Deaconess Clinical Research

Evansville, Indiana, United States

Site Status

Deaconess Clinic

Newburgh, Indiana, United States

Site Status

Kentucky Pediatrics/Adult Research

Bardstown, Kentucky, United States

Site Status

Owensboro Pediatrics

Owensboro, Kentucky, United States

Site Status

Ohio Pediatric Research Association

Dayton, Ohio, United States

Site Status

Coastal Pediatric Research

Charleston, South Carolina, United States

Site Status

DCOL Center for Clinical Research

Longview, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

3389-1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.